Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Ovarian Cancer
  •  Adjuvant Therapy
  •  Endoscopy Methods
  •  Radiation Therapy
  •  Pancreatic Cancer
  •  Carcinomas
  •  Immunotherapy
  •  Colon Cancer

Abstract

Citation: Clin Oncol. 2023;8(1):1994.DOI: 10.25107/2474-1663.1994

Inducing Anti-Tumor Immune Responses in Lung Adenocarcinoma: High-Dose of Ascorbic Acid Combined with Arginine and Magnesium Sulfate

Yu H, Wang R, Gao Y, Zhang J, Gao J, Lu F, Chen Z, Xia Y, Hou Y, Li L, Wang L, Moreira P, Chang L and Li W

Department of Radiation Oncology, The Third Affiliated Hospital of Kunming Medical University, China
International Healthcare Management Research and Development Centre, Shandong First Medical University, China
Department of Biology, Medicine and Health, The University of Manchester, UK
These authors contributed equally to this work

*Correspondance to: [email protected] 

 PDF  Full Text Research Article | Open Access

Abstract:

Evidence on the anti-cancer effect of high-dose Ascorbic Acid (AA) has been generated from several basic and clinical studies. AA can increase the level of Reactive Oxygen Species (ROS) through oxidative stress, modulate tumor immunity. However, a model using “continually intravenous pump of AA for 24 h” has not been widely reported. We treated 4 palliative patients using this approach combining the metabolic mechanisms of AA in the body and possible synergy mechanisms with arginine and magnesium ion. The results show significantly improved survival in two patients with advanced Lung Adenocarcinoma (LUAD) who received this combination therapy and no serious adverse events occurring. Therefore, we explored a high-dose AA combination with arginine and magnesium sulfate with exhibited synergistic anti-tumor effects in LUAD, which have significantly improved anti-cancer effects and enhance anti-tumor immunity in vitro and in vivo. This study provides a contribution to a debate on a new high-efficiency and low-toxicity combination therapy in future clinical practice, potentially improving the prognosis of patients with LUAD.
Graphical Abstract: Image 1.

Keywords:

Ascorbic acid; Arginine; Magnesium sulfate; Lung adenocarcinoma; ROS; Antitumor immunity

Cite the Article:

Yu H, Wang R, Gao Y, Zhang J, Gao J, Lu F, et al. Inducing Anti-Tumor Immune Responses in Lung Adenocarcinoma: High-Dose of Ascorbic Acid Combined with Arginine and Magnesium Sulfate. Clin Oncol. 2023;8:1994..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Analysis of CMTM6 and CMTM4 Expression as Potential Regulators of the PD-L1 Protein and its Association with Prognosis in Gliomas
 Abstract  PDF  Full Text
Outcome of Allogeneic Bone Marrow Transplantation for Acute Myeloid Leukemia Following Single Agent Induction with Hypomethylation
 PDF  Full Text
View More...